FDA publishes discussion paper on generative AI-enabled medical devices
The FDA has issued a discussion paper on regulating generative AI-enabled medical devices and set a deadline for expert comments. It is also seeking nurses' views, with the window closing on 19 October.
Who is affected and how
- medtech company
- Companies should submit comments before the deadline, as the discussion paper lays the groundwork for the future regulatory framework for generative AI devices.
- health policy
- The planned framework could also become a benchmark for regulators in other markets.
Sources
- The FDA’s GenAI proposal: evolving regulation for an evolved medtech eramedical device network · Oct 13, 2026
- The FDA’s GenAI proposal: evolving regulation for an evolved medtech era - Medical Device Networkmedicaldevice-network.com · Oct 13, 2026
- Your Medical Device Has Something to Say. Is the FDA Ready?thedevicefiles.substack.com · Oct 14, 2026
- Due Date Reminder for FDA Discussion Paper on Considerations for the Regulation of Generative AI-Enabled Medical Devicescontent.govdelivery.com · Oct 13, 2026
- FDA AI enabled medical devices top 1,500 authorisationsmedigear.uk · Oct 16, 2026
- ASE Submits Comments on FDA’s GenAI-Enabled Medical Device Discussion Paper – ASEasecho.org · Oct 16, 2026
- The FDA Wants Nurses' Take on AI Devices. The Window Closes Oct. 19 | NurseSavvynursesavvy.com · Oct 12, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.